Analysis Zepp Health Corporation (ZEPP)
5/30/2024
Analysis of Zepp Health Corporation (ZEPP)
Zepp Health Corporation, formerly known as Huami Corporation, is showing some interesting trends based on the provided data. Here are a few key points from the recent data:1. **Price Movement**: The closing prices have been fluctuating between 0.74 and 0.935, showing some volatility in the stock.
2. **Technical Indicators**:
- **RSI Indicator**: The Relative Strength Index (RSI) values are mostly below 50, indicating a bearish sentiment in the stock.
- **MACD Indicator**: The Moving Average Convergence Divergence (MACD) values are negative, suggesting a bearish trend.
- **Moving Averages**: The Simple Moving Average (SMA), Exponential Moving Average (EMA), and Weighted Moving Average (WMA) are all showing a downward trend, indicating a bearish sentiment.
3. **Price Levels**: The stock has been trading within a range of 0.74 to 0.935, with recent prices closer to the lower end of the range.
4. **Overall Sentiment**: Based on the technical indicators and moving averages, the overall sentiment for Zepp Health Corporation appears to be bearish in the short term.
Investors and traders may want to closely monitor the stock for any potential trend reversals or significant developments that could impact its price movement.
Earnings
The company's results for the most recent quarter, ending on April 30, 2025, have not been provided at this time. The previous quarter's results, ending on February 27, 2025, were handled by the transfer agent. The quarter before that, ending on January 31, 2025, had results released after hours. The results for the quarter ending on October 31, 2024, were not provided at the time. However, for the quarter ending on August 1, 2024, the company had an EPS estimate of 1.32.Main Statystic ðŸ§
The data provided includes financials, stock statistics, valuation metrics, stock price summary, and dividends and splits information for a specific company.In terms of financials, the company has strong operating cash flow and levered free cash flow, with a positive current ratio and a high total debt to equity ratio. The profit margin and operating margin are also healthy, indicating efficient operations. The company's fiscal year ends in September 2023, and the most recent quarter reported is March 2024. The company shows good returns on assets and equity.
Looking at stock statistics, the company has a low short ratio and a significant percentage of shares held by institutions. The stock price summary shows volatility within a fifty-two week range and provides moving averages for 50 and 200 days.
Valuation metrics suggest the stock may be overvalued based on the PEG ratio and price to earnings ratios. The company's market capitalization and enterprise value are substantial compared to its financial metrics.
Lastly, dividends and splits information show a history of dividend payments and a recent split. The company has a moderate dividend yield and payout ratio.
Income statement 💸
These are the revenues. Here are the conclusions:1. The company's sales have been increasing steadily over the past four years, from $274.5 billion in 2020 to $383.3 billion in 2023.
2. The gross profit margin has been relatively stable, ranging from 38% to 44% over the same period.
3. Operating income has also shown a consistent growth trend, reaching $114.3 billion in 2023 from $66.3 billion in 2020.
4. Net income has been increasing year over year, with a significant jump from $57.4 billion in 2020 to $97 billion in 2023.
5. Earnings per share (EPS) have shown a slight fluctuation but have generally been on an upward trajectory.
6. The company has been able to maintain a healthy EBITDA margin, indicating efficient operational performance.
7. Despite an increase in income tax expenses, the company's profitability has improved over the years.
8. Overall, the financial performance of the company in terms of revenues has been positive and shows a growth trend.
Balance Sheet
These are balance sheets. Here are the conclusions:1. The total assets have been increasing over the years, from $323.9 billion in 2018 to $352.8 billion in 2023.
2. Current assets have fluctuated but generally increased, indicating improved liquidity.
3. Non-current assets have also shown an increasing trend, suggesting long-term investment and growth.
4. Total liabilities have increased from $255.4 billion in 2018 to $290.4 billion in 2023.
5. Shareholders' equity has shown a positive trend, increasing from $107.1 billion in 2018 to $62.1 billion in 2023.
6. The company has been relying more on non-current liabilities over the years.
7. Accumulated depreciation has been consistently high, indicating significant wear and tear on assets.
8. The company has been investing more in machinery, furniture, and equipment over the years.
Cash Flow 💶
This is the cash flow statement. Here are some conclusions we can draw from the data:1. The company's free cash flow has been fluctuating over the years, with the highest value in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing year over year, indicating improved operational efficiency.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. The end cash position has also been fluctuating, reaching its highest value in 2020.
5. Financing activities show a pattern of common stock repurchase, issuance of long-term debt, and payment of dividends.
6. Investing activities include the sale and purchase of investments, as well as capital expenditures.
7. Overall, the company seems to be managing its cash flow effectively, with a focus on operational performance and strategic investments.
Earnings estimate
Based on the analysts' estimates for future quarterly and annual earnings per share:1. For the current quarter ending on June 30, 2024, the average estimated EPS is $1.33, which is higher than the EPS of $1.26 from the same quarter a year ago. The range of estimates is between $1.27 and $1.36, as provided by 26 analysts.
2. For the next quarter ending on September 30, 2024, the average estimated EPS is $1.53, compared to $1.46 from the previous year. The estimates range from $1.44 to $1.63, based on 25 analysts' forecasts.
3. Looking at the current fiscal year ending on September 30, 2024, the average estimated EPS is $6.59, an increase from the previous year's EPS of $6.13. The analysts' estimates range from $6.43 to $6.92, with insights from 39 analysts.
4. For the next fiscal year ending on September 30, 2025, the average estimated EPS is $7.23, with a range of estimates between $6.40 and $7.90. This data is based on forecasts provided by 39 analysts.
Overall, the analysts are predicting growth in earnings per share both for the upcoming quarters and the next fiscal years, indicating positive expectations for the company's performance.
Revenue estimate
Based on the analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:1. For the current quarter ending on June 30, 2024, the average sales estimate is $83,776,900,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 24.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $92,375,300,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 24.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $386,681,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 37.
4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $411,555,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 37.
These estimates suggest a moderate growth trend in both quarterly and annual sales for the company, with slightly higher growth expected in the next fiscal year compared to the current one.
Growth estimates
Based on the consensus estimates provided:- The current year growth rate is 7.5%
- The next quarter growth rate is 4.8%
- The current quarter growth rate is 5.6%
- The next year growth rate is 9.7%
- The next 5 years compound annual growth rate (CAGR) is 11%
- The past 5 years compound annual growth rate (CAGR) is 20.15%
It can be observed that the company is expected to experience a significant increase in growth compared to the past 5 years, with a particularly high growth rate projected for the next 5 years. This indicates positive expectations and potential for expansion in the company's performance.
Price target
The analysts' forecast for the future price of the security is as follows:- Low: $164
- High: $250
- Median: $200
- Average: $202.26
- Current price: $191.57
- Currency: USD
Based on these forecasts, we can see that the analysts have a wide range of opinions on the future price of the security, with the low end at $164 and the high end at $250. The median forecast is $200, which is close to the current price of $191.57. The average forecast is slightly higher at $202.26. It's important to consider these different perspectives when making investment decisions.
MACD of ZEPP
This is not investment advice. Remember to verify the information provided here.
Get access to the full analysis
- Over 35 000 indexes
- CFD, Forex, Crypto and Stocks Exchange
- Over 150 Indicators
- Pattern and candle analysis
- Support and resistance levels
- Fundamental, technical and sentimental analysis
- Power from AI
